Coya Therapeutics CEO Discusses Company's Treatment Pipeline
Pharmaceutical Executive
by
8h ago
In an interview with Pharm Exec Associate Editor Don Tracy, Howard Berman, Chairman, CEO, Coya Therapeutics offers a look at the organization's pipeline ..read more
Visit website
FDA Approves Label Update for Gilead’s Biktarvy to Include Pregnant Adults With HIV
Pharmaceutical Executive
by
8h ago
Approval update comes as a result of findings from Study 5310, which addressed Biktarvy’s pharmacokinetics, safety, and efficacy during pregnancy and postpartum periods in patients with HIV ..read more
Visit website
FDA Approves Pfizer’s Beqvez for the Treatment of Adults with Moderate to Severe Hemophilia B
Pharmaceutical Executive
by
8h ago
Beqvez, a one-time gene therapy, offers hope to patients with moderate to severe hemophilia B who use regular factor IX prophylaxis, suffer severe hemorrhages, or recurrent serious bleeding ..read more
Visit website
Going Beyond Visuals to Connect with Diverse Audiences
Pharmaceutical Executive
by
12h ago
In this Pharmaceutical Executive video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One, discusses what other tactics healthcare marketers can utilize to connect with diverse audiences on a deeper level ..read more
Visit website
CVS Health Announces New Work Force Development and Community Center in Louisiana
Pharmaceutical Executive
by
15h ago
The center will offer local residents with opportunities and training to enter the pharmacy work force ..read more
Visit website
Solving the First Mile Problem: Q&A with Mark Melton
Pharmaceutical Executive
by
15h ago
Melton, customer advocacy executive at Magnolia, discusses how new technologies can be used to ensure data is accurate ..read more
Visit website
Pharma Pulse 4/26/24: 20 States Select Direct Care Workforce Enhancement Programs by HHS, Do Assigned Roles in Clinical Trials Affect Patient-Reported Outcomes? & more
Pharmaceutical Executive
by
15h ago
The latest news for pharma industry insiders ..read more
Visit website
Novartis, Medicines for Malaria Venture Release Positive Results from Phase II/III Trial of Coartem for Infants with Malaria
Pharmaceutical Executive
by
1d ago
Companies reported that the new formulation of Coartem met required pharmacokinetic profiles and displayed promising efficacy and safety treating malaria in infants ..read more
Visit website
FDA Approves Utility Therapeutics’ Pivya to Treat Uncomplicated Urinary Tract Infections in Adult Females
Pharmaceutical Executive
by
1d ago
Pivya has shown efficacy against bacteria strains such as Escherichia coli, Proteus mirabilis, and Staphylococcus saprophyticus ..read more
Visit website
Bernie Sanders Announces Investigation into Ozempic and Wegovy Pricing
Pharmaceutical Executive
by
1d ago
Sanders wrote a letter to Novo Nordisk announcing the investigation ..read more
Visit website

Follow Pharmaceutical Executive on FeedSpot

Continue with Google
Continue with Apple
OR